Risk of Bias and Brand Explain the Observed Inconsistency in Trials on Glucosamine for Symptomatic Relief of Osteoarthritis: A Meta-Analysis of Placebo-Controlled Trials-Reference-Cited by-同舟云学术

Risk of Bias and Brand Explain the Observed Inconsistency in Trials on Glucosamine for Symptomatic Relief of Osteoarthritis: A Meta-Analysis of Placebo-Controlled Trials

Published:2014-11-24 Issue:12 Volume:66 Page:1844-1855
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Eriksen Patrick¹,Bartels Else M.¹,Altman Roy D.²,Bliddal Henning¹,Juhl Carsten³,Christensen Robin⁴

Affiliation:

1. The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; Copenhagen Denmark

2. David Geffen School of Medicine, University of California; Los Angeles

3. University of Southern Denmark; Odense M Denmark

4. The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, and University of Southern Denmark; Odense M Denmark

Funder

Oak Foundation

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22376/fullpdf

Reference69 articles.

1. Pathogenesis and management of pain in osteoarthritis;Dieppe;Lancet,2005

2. Criteria for classification of clinical osteoarthritis;Altman;J Rheumatol,1991

3. The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments;Felson;Arthritis Rheum,2001